Friday 6 November 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.

Revenue: +10.9%
EPS: −351.9%
Free cash flow: −11.5%
Total debt: +3.28%

Quarter to September 2026, against a year earlier

169.01 9.19 −5.16%

Follow RGEN

Alert me

Market cap: $10.8B
P/E: 0.0×
Fwd P/E: −615×
Dividend yield: —
F-score: 6/9
Altman Z: 7.49
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Repligen Corporation (RGEN) P/E ratio

Alert me on P/E ratio

Repligen Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 5,725× (November 2025) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RGEN/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Repligen Corporation P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RGEN/metrics/pe-ratio">Repligen Corporation (RGEN) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	188×	—
FY2024	0.0×	—
FY2023	268×	454.85%
FY2022	48.2×	(57.40%)
FY2021	113×	(32.67%)
FY2020	168×	(18.22%)
FY2019	206×	48.11%
FY2018	139×	173.38%
FY2017	50.8×	(42.96%)
FY2016	89.0×	(8.77%)

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	182×	42.05%
Mar 2026	128×	(32.00%)
Dec 2025	188×	(95.77%)
43 more quarters	Free account

Against its own ten years

Low 0.0× High 5,725×

Ten-year median 110×

Current reading's percentile 9

Company	P/E ratio
RGEN Repligen Corporation	n/m
BAX Baxter International Inc. compare	n/m
BLCO Bausch + Lomb Corporation compare	n/m
TFX Teleflex Incorporated compare	n/m
COO The Cooper Companies, Inc. compare	21.7×
ALGN Align Technology, Inc. compare	23.1×
AVTR Avantor, Inc. compare	30.3×
ATR AptarGroup, Inc. compare	34.6×
SOLV Solventum Corporation compare	97.3×
Medical Instruments & Supplies industry median	30.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Repligen Corporation (RGEN) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on RGEN

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on RGEN

Stockrow Weekly